Bayesian Capital Management’s Sangamo Therapeutics SGMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-31,000
| Closed | -$128K | – | 987 |
|
|
2022
Q2 | $128K | Buy |
31,000
+8,240
| +36% | +$34K | 0.02% | 664 |
|
|
2022
Q1 | $132K | Buy |
+22,760
| New | +$132K | 0.02% | 684 |
|
|
2020
Q3 | – | Sell |
-53,700
| Closed | -$481K | – | 674 |
|
|
2020
Q2 | $481K | Sell |
53,700
-56,300
| -51% | -$504K | 0.11% | 243 |
|
|
2020
Q1 | $701K | Buy |
+110,000
| New | +$701K | 0.15% | 205 |
|
|
2018
Q3 | – | Sell |
-13,015
| Closed | -$185K | – | 776 |
|
|
2018
Q2 | $185K | Sell |
13,015
-17,393
| -57% | -$247K | 0.04% | 529 |
|
|
2018
Q1 | $578K | Buy |
+30,408
| New | +$578K | 0.15% | 239 |
|